Laura M. Calvi
Affiliations: | University of Rochester, Rochester, NY |
Area:
Pathology, Cell BiologyGoogle:
"Laura Calvi"Children
Sign in to add trainee| Jonathan M. Weber | grad student | 2010 | Rochester |
| Rebecca L. Porter | grad student | 2011 | Rochester |
| Benjamin J. Frisch | grad student | 2012 | Rochester |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kaszuba CM, Rodems BJ, Sharma S, et al. (2023) Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Journal of Visualized Experiments : Jove |
| Quarato ER, Salama NA, Li AJ, et al. (2023) Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling. Cell Death & Disease. 14: 428 |
| Kfoury YS, Ji F, Jain E, et al. (2023) The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression. Blood Advances |
| Kawano H, Kawano Y, Yu C, et al. (2023) Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells. Cells. 12 |
| Kawano Y, Kawano H, Ghoneim D, et al. (2023) Myelodysplastic syndromes disable human CD271 VCAM1 CD146 niches supporting normal hematopoietic stem/progenitor cells. Biorxiv : the Preprint Server For Biology |
| Zhang H, Liesveld JL, Calvi LM, et al. (2023) The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies. Bone Research. 11: 15 |
| Lynch OF, Calvi LM. (2022) Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review. Cells. 11 |
| Seyfried AN, McCabe A, Smith JNP, et al. (2021) CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia. Leukemia |
| Calvi LM. (2021) FGF-23: a novel actor in stem cell mobilization. Blood. 137: 1434-1436 |
| Ackun-Farmmer MA, Soto CA, Lesch ML, et al. (2021) Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21402 |